INSR and Alzheimer disease: However, the brains of AD patients showed downregulated insulin receptors, pointing toward a role of neuronal insulin resistance in AD etiology (Steculorum et al., 2014; de la Monte, 2017), and so several clinical trials have focused on the administration of insulin to treat or prevent dementia (Lee et al., 2018).